
Topline Results Released on IMG-007 Monoclonal Antibody for Alopecia Areata
New topline phase 2a findings have been announced by Inmagene Biopharmaceuticals, demonstrating positive results following treatment with a humanized IgG1 monoclonal antibody known as IMG-007 in patients with severe alopecia areata.1 The April 24 …